Health tech company SOPHiA GENETICS has welcomed Bram Goorden to its Executive team as Chief Commercial Officer and Head of North America. In his role, Mr. Goorden will be based in Boston, and help to facilitate the company’s goals to triple its US-based team.
"Bram is an amazing addition to our leadership team as he is well-versed in building top performing teams and developing lasting commercial relationships with healthcare stakeholders that are of immense benefit to all involved,” said SOPHiA GENETICS founder and CEO Jurgi Camblong. “He will be a great driver of our US and Global expansion plans moving forward as he champions the future of Data-Driven Medicine in both the Clinical and BioPharma Business Units."
Mr. Goorden is a Belgian national with more than 20 years of experience in the life science field. He comes to SOPHiA from Foundation Medicine Inc., where he served as VP of International Business and Partnering. He has also served in leadership positions at Prometheus Labs, Eli Lilly and UCB Pharma.
"I am thrilled to join the SOPHiA team. Our universal Platform is democratizing Data-Driven Medicine in an unparalleled fashion,” said Mr. Goorden. “Together, we enable healthcare providers to fully utilize the power of decentralized genomic and multimodal data in their efforts to improve patient outcomes. It's a privilege to help grow access to our solution for both clinicians and biopharma partners in my role as Chief Commercial Officer."